Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Triptorelin Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Triptorelin Pamoate
  • 1.3.3 Triptorelin Embonate
  • 1.3.4 Triptorelin Acetate
• 1.4 Market Segment by Application
  • 1.4.1 Global Triptorelin Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacies
  • 1.4.3 Retail Pharmacies
  • 1.4.4 Online Pharmacies
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Triptorelin Market Size
  • 2.1.1 Global Triptorelin Revenue 2014-2025
  • 2.1.2 Global Triptorelin Sales 2014-2025
• 2.2 Triptorelin Growth Rate by Regions
  • 2.2.1 Global Triptorelin Sales by Regions 2014-2019
  • 2.2.2 Global Triptorelin Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Triptorelin Sales by Manufacturers
  • 3.1.1 Triptorelin Sales by Manufacturers 2014-2019
  • 3.1.2 Triptorelin Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Triptorelin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Triptorelin Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Triptorelin Market Concentration Ratio (CR5 and HHI)
• 3.3 Triptorelin Price by Manufacturers
• 3.4 Key Manufacturers Triptorelin Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Triptorelin Market
• 3.6 Key Manufacturers Triptorelin Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Triptorelin Pamoate Sales and Revenue (2014-2019)
  • 4.1.2 Triptorelin Embonate Sales and Revenue (2014-2019)
  • 4.1.3 Triptorelin Acetate Sales and Revenue (2014-2019)
• 4.2 Global Triptorelin Sales Market Share by Type
• 4.3 Global Triptorelin Revenue Market Share by Type
• 4.4 Triptorelin Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Triptorelin Sales by Application

6 United States

• 6.1 United States Triptorelin Breakdown Data by Company
• 6.2 United States Triptorelin Breakdown Data by Type
• 6.3 United States Triptorelin Breakdown Data by Application

7 European Union

• 7.1 European Union Triptorelin Breakdown Data by Company
• 7.2 European Union Triptorelin Breakdown Data by Type
• 7.3 European Union Triptorelin Breakdown Data by Application

8 China

• 8.1 China Triptorelin Breakdown Data by Company
• 8.2 China Triptorelin Breakdown Data by Type
• 8.3 China Triptorelin Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Triptorelin Breakdown Data by Company
• 9.2 Rest of World Triptorelin Breakdown Data by Type
• 9.3 Rest of World Triptorelin Breakdown Data by Application
• 9.4 Rest of World Triptorelin Breakdown Data by Countries
  • 9.4.1 Rest of World Triptorelin Sales by Countries
  • 9.4.2 Rest of World Triptorelin Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Ipsen
  • 10.1.1 Ipsen Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Triptorelin
  • 10.1.4 Triptorelin Product Introduction
  • 10.1.5 Ipsen Recent Development
• 10.2 Bachem
  • 10.2.1 Bachem Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Triptorelin
  • 10.2.4 Triptorelin Product Introduction
  • 10.2.5 Bachem Recent Development
• 10.3 Chengdu Tiantaishan pharmaceutical
  • 10.3.1 Chengdu Tiantaishan pharmaceutical Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Triptorelin
  • 10.3.4 Triptorelin Product Introduction
  • 10.3.5 Chengdu Tiantaishan pharmaceutical Recent Development
• 10.4 Ferring Pharmaceuticals
  • 10.4.1 Ferring Pharmaceuticals Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Triptorelin
  • 10.4.4 Triptorelin Product Introduction
  • 10.4.5 Ferring Pharmaceuticals Recent Development
• 10.5 Tecnofarma
  • 10.5.1 Tecnofarma Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Triptorelin
  • 10.5.4 Triptorelin Product Introduction
  • 10.5.5 Tecnofarma Recent Development
• 10.6 Reddy's Laboratories
  • 10.6.1 Reddy's Laboratories Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Triptorelin
  • 10.6.4 Triptorelin Product Introduction
  • 10.6.5 Reddy's Laboratories Recent Development
• 10.7 Arbor Pharmaceutical
  • 10.7.1 Arbor Pharmaceutical Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Triptorelin
  • 10.7.4 Triptorelin Product Introduction
  • 10.7.5 Arbor Pharmaceutical Recent Development
• 10.8 Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
  • 10.8.1 Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.) Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Triptorelin
  • 10.8.4 Triptorelin Product Introduction
  • 10.8.5 Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.) Recent Development
• 10.9 Debiopharm Group
  • 10.9.1 Debiopharm Group Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Triptorelin
  • 10.9.4 Triptorelin Product Introduction
  • 10.9.5 Debiopharm Group Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Triptorelin Sales Channels
  • 11.2.2 Triptorelin Distributors
• 11.3 Triptorelin Customers

12 Market Forecast

• 12.1 Global Triptorelin Sales and Revenue Forecast 2019-2025
• 12.2 Global Triptorelin Sales Forecast by Type
• 12.3 Global Triptorelin Sales Forecast by Application
• 12.4 Triptorelin Forecast by Regions
  • 12.4.1 Global Triptorelin Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Triptorelin Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Triptorelin is a decapeptide analogue of Luteinising Hormone-Releasing Hormone (LHRH, also called gonadotropin-releasing hormone [GnRH]). Triptorelin is extensively used in palliative treatment of hormone dependent advanced prostate cancer.
In 2019, the market size of Triptorelin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Triptorelin.

This report studies the global market size of Triptorelin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Triptorelin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Ipsen
Bachem
Chengdu Tiantaishan pharmaceutical
Ferring Pharmaceuticals
Tecnofarma
Reddy's Laboratories
Arbor Pharmaceutical
Teva Pharmaceutical Industries Ltd. (Actavis Specialty Pharmaceuticals Co.)
Debiopharm Group

Market Segment by Product Type
Triptorelin Pamoate
Triptorelin Embonate
Triptorelin Acetate

Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Triptorelin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Triptorelin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Triptorelin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025